Clinical trial
Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients…
NCT00321217 · Radboud University Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00321217 |
|---|---|
| Title | Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis |
| Official title | Pharmacogenomics of Anti-TNF Treatment in Patients With Rheumatoid Arthritis |
| Lead sponsor | Radboud University Medical Center, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Rheumatoid Arthritis |
| Enrollment | 700 |
| Start date | May 1, 2004 |
| Primary completion | Nov 1, 2013 |
| Completion | Apr 1, 2014 |
| First posted | May 3, 2006 |
| Last update posted | Aug 16, 2012 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: